Country: Taiwan
Language: Chinese
Source: 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)
GLUCOSE ANHYDROUS;;CALCIUM CHLORIDE DIHYDRATE;;L-ISOLEUCINE;;L-LEUCINE;;LYSINE L- (HCL);;L-METHIONINE;;L-PHENYLALANINE;;L-THREONINE;;L-TRYPTOPHAN;;L-VALINE;;ARGININE L- (MONOGLUTAMATE);;HISTIDINE L- (HCL MONOHYDRATE);;L-ALANINE;;L-ASPARTIC ACID;;GLUTAMIC ACID L-;;GLYCINE (EQ TO AMINOACETIC ACID)(EQ TO GLYCOCOLL);;L-PROLINE;;L-SERINE;;MAGNESIUM ACETATE TETRAHYDRATE;;SODIUM ACETATE TRIHYDRATE (EQ TO SODIUM ACETATE 3H2O );;POTASSIUM DIHYDROGEN PHOSPHATE;;POTASSIUM HYDROXIDE;;SODIUM HYDROXIDE
臺灣柏朗股份有限公司 台北市松山區健康路152號9樓 (23525106)
B05BA10
注射劑
SODIUM ACETATE TRIHYDRATE (EQ TO SODIUM ACETATE 3H2O ) (4008000670) 1.63MG; CALCIUM CHLORIDE DIHYDRATE (4012000350) 0.6MG; MAGNESIUM ACETATE TETRAHYDRATE (4012001450) 1.08MG; GLUCOSE ANHYDROUS (4020000750) 240MG; L-ALANINE (4020100202) 8.49MG; L-ASPARTIC ACID (4020100402) 2.63MG; GLUTAMIC ACID L- (4020100702) 6.14MG; L-ISOLEUCINE (4020101002) 4.11MG; L-LEUCINE (4020101202) 5.48MG; L-METHIONINE (4020101502) 3.42MG; L-PHENYLALANINE (4020101702) 6.15MG; L-PROLINE (4020101802) 5.95MG; L-SERINE (4020101902) 5.25MG; L-THREONINE (4020102002) 3.18MG; L-TRYPTOPHAN (4020102102) 1MG; L-VALINE (4020102302) 4.54MG; GLYCINE (EQ TO AMINOACETIC ACID)(EQ TO GLYCOCOLL) (4020102400) 2.89MG; ARGININE L- (MONOGLUTAMATE) (4020109342) 4.73MG; HISTIDINE L- (HCL MONOHYDRATE) (4020109922) 2.19MG; LYSINE L- (HCL) (4020191312) 3.98MG; POTASSIUM DIHYDROGEN PHOSPHATE (5612001920) 2.00MG; POTASSIUM HYDROXIDE (9600024100) 0.62MG; SODIUM HYDROXIDE (9600028200) 1.14MG
塑膠袋裝
製 劑
限由醫師使用
B.BRAUN MEDICAL AG ROUTE DE SORGE 9 CH-1023 CRISSIER SWITZERLAND CH
combinations
無法經口服攝食或腸道吸收營養、功能不全有禁忌症時,對中等到嚴重異化作用狀態的病人的靜脈營養提供氨基酸、 葡萄糖、電解質和液體。欣保康優靜脈營養輸注液適用於成人和 2 到17 歲的兒童。
有效日期: 2024/10/16; 英文品名: NUTRIFLEX SPECIAL
2019-08-07
schwarz Dokument = 210 x 980 mm 2 Seiten Lätus 136 TW___725 725/NP72565/1120 Production site: Crissier Font size: 9 pt. G 190446 725/NP72565/1120 1. NAME OF THE MEDICINAL PRODUCT Nutriflex special solution for infusion 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Amounts of active substances in both the 1000 ml and 1500 ml sizes of the product are given below. COMPOSITION IN 1000 ML IN 1500 ML FROM THE UPPER CHAMBER (500 ML) FROM THE UPPER CHAMBER (750 ML) Isoleucine 4.11 g 6.17 g Leucine 5.48 g 8.22 g Lysine hydrochloride (equivalent to lysine:) 4.97 g (3.98 g) 7.46 g (5.97 g) Methionine 3.42 g 5.13 g Phenylalanine 6.15 g 9.23 g Threonine 3.18 g 4.77 g Tryptophan 1.00 g 1.50 g Valine 4.54 g 6.81 g Arginine monoglutamate (equivalent to arginine:) (equivalent to glutamic acid:) 8.72 g (4.73 g) (3.99 g) 13.08 g (7.10 g) (5.99 g) Histidine hydrochloride monohydrate (equivalent to histidine:) 2.96 g (2.19 g) 4.44 g (3.29 g) Alanine 8.49 g 12.74 g Aspartic acid 2.63 g 3.95 g Glutamic acid 2.15 g 3.23 g Glycine 2.89 g 4.34 g Proline 5.95 g 8.93 g Serine 5.25 g 7.88 g Magnesium acetate tetrahydrate 1.08 g 1.62 g Sodium acetate trihydrate 1.63 g 2.45 g Potassium dihydrogen phosphate 2.00 g 3.00 g Potassium hydroxide 0.62 g 0.93 g Sodium hydroxide 1.14 g 1.71 g FROM THE LOWER CHAMBER (500 ML) FROM THE LOWER CHAMBER (750 ML) Glucose monohydrate (equivalent to glucose:) 264.0 g (240.0 g) 396.0 g (360.0 g) Calcium chloride dihydrate 0.60 g 0.90 g ELECTROLYTES: IN 1000 ML IN 1500 ML Sodium 40.5 mmol 60.8 mmol Potassium 25.7 mmol 38.6 mmol Magnesium 5.0 mmol 7.5 mmol Dihydrophosphate 14.7 mmol 22.1 mmol Acetate 22.0 mmol 33.0 mmol Chloride 49.5 mmol 74.3 mmol Calcium 4.1 mmol 6.2 mmol IN 1000 ML IN 1500 ML Amino acid content 70 g 105 g Nitrogen content 10 g 15 g Carbohydrate content 240 g 360 g For the full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Solution for infusion Infusion bag with two compartments Amino acids and glucose solutions: clear, colourless or slightly yellowish aqueous solution IN 1000 ML IN Read the complete document